Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Leukemia
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 


September 2002, Volume 16, Number 9

Table of Contents

< Previous    Issue    Next >
Spotlight on IMATINIB as a Model for Signal Transduction Inhibitors
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha FREE
K Merx, M C Müller, S Kreil, T Lahaye, P Paschka, C Schoch, A Weisser, C Kuhn, U Berger, H Gschaidmeier, R Hehlmann & A Hochhaus
Abstract    Full Article    PDF 1579
Spotlight on IMATINIB as a Model for Signal Transduction Inhibitors
Effects of imatinib on bone marrow engraftment in syngeneic mice FREE
J Hoepfl, C Miething, R Grundler, K S Götze, C Peschel & J Duyster
Abstract    Full Article    PDF 1584
Spotlight on IMATINIB as a Model for Signal Transduction Inhibitors
Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors FREE
J F Dorsey, J M Cunnick, R Lanehart, M Huang, A J Kraker, K N Bhalla, R Jove & J Wu
Abstract    Full Article    PDF 1589
Spotlight on Molecular Targeted Therapy
Sphingosine 1-phosphate as a therapeutic agent FREE
S Spiegel & R Kolesnick
Abstract    Full Article    PDF 1596
Review
CD34+ or CD34-: which is the more primitive? FREE
M Engelhardt, M Lübbert & Y Guo
Abstract    Full Article    PDF 1603
Original Manuscripts
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study FREE
P P Piccaluga, G Visani, S A Pileri, S Ascani, T Grafone, A Isidori, M Malagola, C Finelli, G Martinelli, P Ricci, M Baccarani & S Tura
Abstract    Full Article    PDF 1609
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors FREE
M Oosterveld, P Muus, S Suciu, C Koller, G Verhoef, B Labar, P Wijermans, C Aul, D Fière, D Selleslag, R Willemze, A Gratwohl, A Ferrant, F Mandelli, J Cortes, T de Witte & E Estey for the EORTC, EBMT, SAKK, GIMEMA Leukemia Groups & the MD Anderson Cancer Center
Abstract    Full Article    PDF 1615
Acute megakaryoblastic leukemia: experience of GIMEMA trials FREE
L Pagano, A Pulsoni, M Vignetti, L Mele, L Fianchi, M C Petti, S Mirto, P Falcucci, P Fazi, G Broccia, G Specchia, F Di Raimondo, L Pacilli, P Leoni, S Ladogana, E Gallo, A Venditti, G Avanzi, A Camera, V Liso, G Leone & F Mandelli for the GIMEMA
Abstract    Full Article    PDF 1622
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin) FREE
R A Larson, M Boogaerts, E Estey, C Karanes, E A Stadtmauer, E L Sievers, P Mineur, J M Bennett, M S Berger, C B Eten, M Munteanu, M R Loken, J J M van Dongen, I D Bernstein & F R Appelbaum for the Mylotarg Study Group
Abstract    Full Article    PDF 1627
Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia FREE
A Saudemont, G Buffenoir, A Denys, P Desreumaux, N Jouy, D Hetuin, F Bauters, P Fenaux & B Quesnel
Abstract    Full Article    PDF 1637
Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses FREE
R C Koya, N Kasahara, V Pullarkat, A M Levine & R Stripecke
Abstract    Full Article    PDF 1645
Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell FREE
Z Li, B Fehse, B Schiedlmeier, J Düllmann, O Frank, A R Zander, W Ostertag & C Baum
Abstract    Full Article    PDF 1655
Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells FREE
S Le Gouill, C Pellat-Deceunynck, J-L Harousseau, M-J Rapp, N Robillard, R Bataille & M Amiot
Abstract    Full Article    PDF 1664
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL FREE
P Bader, J Hancock, H Kreyenberg, N J Goulden, D Niethammer, A Oakhill, C G Steward, R Handgretinger, J F Beck & T Klingebiel
Abstract    Full Article    PDF 1668
Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer FREE
G Nichols, K de Castro, L-X Wei, M Griffin, N Lin, A Oratzi, V V V S Murty, A Troxel, L Vahdat & C Hesdorffer
Abstract    Full Article    PDF 1673
Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes FREE
D Ribatti, G Polimeno, A Vacca, A Marzullo, E Crivellato, B Nico, G Lucarelli & F Dammacco
Abstract    Full Article    PDF 1680
Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases FREE
A Borkhardt, C Wuchter, S Viehmann, S Pils, A Teigler-Schlegel, M Stanulla, M Zimmermann, W-D Ludwig, G Janka-Schaub, M Schrappe & J Harbott
Abstract    Full Article    PDF 1685
Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells FREE
J Vilpo, J Hulkkonen, M Hurme & L Vilpo
Abstract    Full Article    PDF 1691
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy FREE
N Boissel, J M Cayuela, C Preudhomme, X Thomas, N Grardel, X Fund, I Tigaud, E Raffoux, P Rousselot, F Sigaux, L Degos, S Castaigne, P Fenaux & H Dombret
Abstract    Full Article    PDF 1699
Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines FREE
W M Liu, P R Oakley & S P Joel
Abstract    Full Article    PDF 1705
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins FREE
M Konopleva, S Konoplev, W Hu, A Y Zaritskey, B V Afanasiev & M Andreeff
Abstract    Full Article    PDF 1713
High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion FREE
K Keeshan, T G Cotter & S L McKenna
Abstract    Full Article    PDF 1725
CD20-induced B cell death can bypass mitochondria and caspase activation FREE
L E van der Kolk, L M Evers, C Omene, S M A Lens, S Lederman, R A W van Lier, M H J van Oers & E Eldering
Abstract    Full Article    PDF 1735
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype FREE
A Cuneo, R Bigoni, F Cavazzini, A Bardi, M G Roberti, P Agostini, E Tammiso, N Ciccone, M Mancini, M Nanni, R De Cuia, M Divona, R La Starza, B Crescenzi, N Testoni, G Rege Cambrin, C Mecucci, F Lo Coco, G Saglio & G Castoldi
Abstract    Full Article    PDF 1745
Large deletions 5' to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemia FREE
C Godon, J Proffitt, N Dastugue, M Lafage-Pochitaloff, M-J Mozziconacci, P Talmant, M Hackbarth, R Bataille & H Avet-Loiseau
Abstract    Full Article    PDF 1752
The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein FREE
S Takahashi & J D Licht
Abstract    Full Article    PDF 1755
Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesis FREE
C R Walkley, Y-D Yuan, R A S Chandraratna & G A McArthur
Abstract    Full Article    PDF 1763
Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis FREE
L Catani, N Vianelli, M Amabile, L Pattacini, L Valdrè, M E Fagioli, M Poli, L Gugliotta, P Moi, M G Marini, G Martinelli, S Tura & M Baccarani
Abstract    Full Article    PDF 1773
Stromal cells from murine embryonic aorta-gonad-mesonephros region, liver and gut mesentery expand human umbilical cord blood-derived CAFCweek6 in extended long-term cultures FREE
N Kusadasi, R A J Oostendorp, W J L M Koevoet, E A Dzierzak & R E Ploemacher
Abstract    Full Article    PDF 1782
HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors FREE
S Pillozzi, M F Brizzi, M Balzi, O Crociani, A Cherubini, L Guasti, B Bartolozzi, A Becchetti, E Wanke, P A Bernabei, M Olivotto, L Pegoraro & A Arcangeli
Abstract    Full Article    PDF 1791
Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL) FREE
H Harasawa, Y Yamada, M Kudoh, K Sugahara, H Soda, Y Hirakata, H Sasaki, S Ikeda, T Matsuo, M Tomonaga, T Nobori & S Kamihira
Abstract    Full Article    PDF 1799
Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro FREE
M Akutsu, Y Furukawa, S Tsunoda, T Izumi, K Ohmine & Y Kano
Abstract    Full Article    PDF 1808
Human AML cells in NOD/SCID mice: engraftment potential and gene expression FREE
R Lumkul, N-C Gorin, M T Malehorn, G T Hoehn, R Zheng, B Baldwin, D Small, S Gore, D Smith, P S Meltzer & C I Civin
Abstract    Full Article    PDF 1818
F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4 FREE
J Kone, J Arroyo, T Savinelli, S Lin, K Boyd, Y Wu, M Nimmakayalu, N G Copeland, N A Jenkins, M Qumsiyeh, P Hu, A Prescott, H Wu, L Yang, B Roe & A S Perkins
Abstract    Full Article    PDF 1827
Clinical activity of arsenic trioxide for the treatment of multiple myeloma FREE
N C Munshi, G Tricot, R Desikan, A Badros, M Zangari, A Toor, C Morris, E Anaissie & B Barlogie
Abstract    Full Article    PDF 1835
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma FREE
P Moreau, R Misbahi, N Milpied, N Morineau, B Mahé, M Vigier, M J Rapp, R Bataille & J L Harousseau
Abstract    Full Article    PDF 1838
Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma FREE
A Krämer, B Schultheis, J Bergmann, A Willer, U Hegenbart, A D Ho, H Goldschmidt & R Hehlmann
Abstract    Full Article    PDF 1844
Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease? FREE
G Buchonnet, F Jardin, N Jean, P Bertrand, F Parmentier, S Tison, S Lepretre, N Contentin, P Lenain, A Stamatoullas-Bastard, H Tilly & C Bastard
Abstract    Full Article    PDF 1852
BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5' regulatory region of the BCL-6 gene FREE
I S Lossos, R Warnke & R Levy
Abstract    Full Article    PDF 1857
Correspondence
The novel t(11;12;18)(q21;q13;q21) represents a variant translocation of the t(11;18)(q21;q21) associated with MALT-type lymphoma FREE
J Dierlamm, E M Murga Penas, M Daibata, H Tagushi, K Hinz, M Baens, J Cools, G Schilling, L Michaux, P Marynen, I Miyoshi & D K Hossfeld
Abstract    Full Article    PDF 1863
Differential bone marrow aspirate DNA yields from commercial extraction kits FREE
R Aplenc, E Orudjev, J Swoyer, B Manke & T Rebbeck
Abstract    Full Article    PDF 1865
Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome FREE
T Taketani, T Taki, J Takita, R Ono, Y Horikoshi, Y Kaneko, M Sako, R Hanada, T Hongo & Y Hayashi
Abstract    Full Article    PDF 1866
DNA profiling and cytogenetic analysis of cell line WSU-CLL reveal cross-contamination with cell line REH (pre B-ALL) FREE
H G Drexler, H Quentmeier, W G Dirks, C C Uphoff & R A F MacLeod
Abstract    Full Article    PDF 1868
Sustained complete remission of recurrent acute myeloid leukaemia with a single dose of gemtuzumab ozogamicin and low-dose interleukin-2 maintenance FREE
M P Radsak, H R Salih, M Sökler, L Kanz & C Denzlinger
Abstract    Full Article    PDF 1870
Complete remission in hypoplastic acute myeloid leukemia induced by G-CSF without chemotherapy: report on three cases FREE
S Nimubona, I Grulois, M Bernard, B Drénou, M Godard, R Fauchet & T Lamy
Abstract    Full Article    PDF 1871
Additional evidence of genetic changes in children with ALL and TEL/AML1 fusion gene FREE
M Jaroscaronová, M Holzerova, V Mihál, J Blatny circ, I Lakomá, J Trka, Z Pikalová, O Hruscaronák & K Indrák
Abstract    Full Article    PDF 1873
Cultures of myeloid progenitor cells in pediatric essential thrombocythemia FREE
L Florensa, L Zamora, C Besses, J J Ortega, P Bastida, T Toll, P Mayayo, B Espinet, F Solé, S Serrano & S Woessner
Abstract    Full Article    PDF 1876
Identification and characterization of rapidly dividing U937 clones with differential telomerase activity and gene expression profiles: role of c-Myc/Mad1 and Id/Ets proteins FREE
X Xiao, S K Phogat, I A Sidorov, J Yang, I Horikawa, D Prieto, J Adelesberger, R Lempicki, J C Barrett & D S Dimitrov
Abstract    Full Article    PDF 1877
Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia FREE
P P Piccaluga, G Visani, G Martinelli, A Isidori, M Malagola, M Rondoni, M Baccarani & S Tura
Abstract    Full Article    PDF 1880
Increased risk of human herpesvirus-8 infection in patients with adult T cell leukemia/lymphoma in Okinawa FREE
J Miyagi, M Masuda, H Uezato, T Sawada, T Miyakuni, I Miyoshi & N Takasu
Abstract    Full Article    PDF 1881
In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37°C, but not with affinity determined at room temperature FREE
E G Haarman, G J L Kaspers, R Pieters, M M A Rottier, M L Den Boer, G E Janka-Schaub & A J P Veerman
Abstract    Full Article    PDF 1882
Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge FREE
C Skrabs, C Müller, H Agis, C Mannhalter & U Jäger
Abstract    Full Article    PDF 1884
Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study FREE
T Reiman, K A Graham, J Wong, A R Belch, R Coupland, J Young, C E Cass & J R Mackey
Abstract    Full Article    PDF 1886
Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL) FREE
G Garcia-Manero, H M Kantarjian, S Kornblau & E Estey
Abstract    Full Article    PDF 1888
Blastic variant of mantle cell lymphoma occurring in immunosuppressed patients FREE
L R Munro, P W Johnston, J R Goodlad & D J Culligan
Abstract    Full Article    PDF 1888
Reply to Munro et al FREE
M Bernard & T Lamy
Abstract    Full Article    PDF 1889
A potential role of erythropoietin in angiogenesis associated with myelodysplastic syndromes FREE
D Ribatti
Abstract    Full Article    PDF 1890
Response to letter from Dr Domenico Ribatti FREE
U Bunworasate, H Arnouk, H Minderman, K L O'Loughlin, S N J Sait, M Barcos, C C Stewart & M R Baer
Abstract    Full Article    PDF 1891
September 2002, Volume 16, Number 9
< Previous    Issue    Next >
Privacy Policy © 2002 Nature Publishing Group